_cropped.png)
Key Services & Capabilities
Combining expert analytical acumen with in-depth market experience
Licensing/Acquisition
Analytics and Support
Maximize value return and insight
on potential targets or partners
-
Deal support, analytics, and terms/
value split analysis -
Business case evaluation, generation, & refinement
-
Commercial due diligence
-
Opportunity/target screens and prioritization
-
C-suite & investor briefs, presentations, and pitches
Modeling and Forecasting
Customized approaches for
unconventional market challenges
-
Company portfolio, and product valuations
and deal term/value split modeling -
P&L models and forecasts: topline utilization/ revenue and commercial
-
Market-tracking and portfolio models
-
Medical device and technology models - including CapEx+consumable spend, services/ support/ licenses, pull-through dynamics
-
Commercial reporting, P&L, and long-term planning
Portfolio/Product Strategy
and Business Planning
Help differentiate and shepherd products
to reach their potential
-
Portfolio strategy, prioritization, and optimization
-
New product commercial strategy and development
-
Positioning and differentiation
-
Business plan development and launch planning
-
Leveraging deep expertise in rare/orphan, specialty, and emerging products
Market Insights and Analytics
Expert analytical acumen to
optimally inform business decisions
-
Market research - primary and secondary, qualitative and quantitative
-
Conjoints and simulators
-
Product profile development, testing, and refinement
-
Engaging diverse stake-holders - thought leaders, clinicians/HCPs, payers, advocates, and patients
-
Product and market performance analysis
Leadership
Shlomo Harnas is a seasoned corporate development professional and fractional exec, with extensive experience in biopharma, medtech, and healthcare across consulting and industry, spanning the US, EU, and emerging markets (BRIC, LatAm).
​
He is the Managing Director of Akrolyth Advisory, working both buy-side and sell-side with industry, VC and PE investors, translational research groups, and startups on buying/selling/licensing, evaluating, developing, and commercializing new therapies and products.
He was previously the North America Commercial Lead for Grünenthal, a Germany-based global pharma and the global Commercial Lead for their mid-late stage rare disease program. Prior to that, he was the go-to diligence/LM&A lead with Navigant Consulting’s global Life Science practice, as well as a member of Leerink Swann’s advisory group and of Clarion Healthcare’s strategy practice. Shlomo also works with startups and accelerators as a mentor, advisor, and investor.
​
Throughout his career, Shlomo has been especially valued for his depth of insight, versatility and speed in gaining mastery of new subjects, and ability to navigate complexity and provide structure and clarity to challenging questions.
​
Shlomo holds a Master’s degree in Biology from the Massachusetts Institute of Technology, where he was a Presidential Doctoral Fellow, and a Master’s/Bachelor’s in Biochemistry and Mathematics from Brandeis University, summa cum laude, with highest honors, where he was a Goldwater Scholar and Howard Hughes Medical Institute fellow.
​
He has lived in 4 countries, is fluent in English and Portuguese, and is conversant in 3 more languages.
Contact Us
Let us know how we can best serve your needs!
Madison, NJ | Westminster, CO | Dallas, TX
Phone: +1 833-257-6598 (1-833-AKROLYTH)
